Cargando…

Mass spectrometric strategies for the investigation of biomarkers of illicit drug use in wastewater

The analysis of illicit drugs in urban wastewater is the basis of wastewater‐based epidemiology (WBE), and has received much scientific attention because the concentrations measured can be used as a new non‐intrusive tool to provide evidence‐based and real‐time estimates of community‐wide drug consu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández, Félix, Castiglioni, Sara, Covaci, Adrian, de Voogt, Pim, Emke, Erik, Kasprzyk‐Hordern, Barbara, Ort, Christoph, Reid, Malcolm, Sancho, Juan V., Thomas, Kevin V., van Nuijs, Alexander L.N., Zuccato, Ettore, Bijlsma, Lubertus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191649/
https://www.ncbi.nlm.nih.gov/pubmed/27750373
http://dx.doi.org/10.1002/mas.21525
_version_ 1783363755197857792
author Hernández, Félix
Castiglioni, Sara
Covaci, Adrian
de Voogt, Pim
Emke, Erik
Kasprzyk‐Hordern, Barbara
Ort, Christoph
Reid, Malcolm
Sancho, Juan V.
Thomas, Kevin V.
van Nuijs, Alexander L.N.
Zuccato, Ettore
Bijlsma, Lubertus
author_facet Hernández, Félix
Castiglioni, Sara
Covaci, Adrian
de Voogt, Pim
Emke, Erik
Kasprzyk‐Hordern, Barbara
Ort, Christoph
Reid, Malcolm
Sancho, Juan V.
Thomas, Kevin V.
van Nuijs, Alexander L.N.
Zuccato, Ettore
Bijlsma, Lubertus
author_sort Hernández, Félix
collection PubMed
description The analysis of illicit drugs in urban wastewater is the basis of wastewater‐based epidemiology (WBE), and has received much scientific attention because the concentrations measured can be used as a new non‐intrusive tool to provide evidence‐based and real‐time estimates of community‐wide drug consumption. Moreover, WBE allows monitoring patterns and spatial and temporal trends of drug use. Although information and expertise from other disciplines is required to refine and effectively apply WBE, analytical chemistry is the fundamental driver in this field. The use of advanced analytical techniques, commonly based on combined chromatography—mass spectrometry, is mandatory because the very low analyte concentration and the complexity of samples (raw wastewater) make quantification and identification/confirmation of illicit drug biomarkers (IDBs) troublesome. We review the most‐recent literature available (mostly from the last 5 years) on the determination of IDBs in wastewater with particular emphasis on the different analytical strategies applied. The predominance of liquid chromatography coupled to tandem mass spectrometry to quantify target IDBs and the essence to produce reliable and comparable results is illustrated. Accordingly, the importance to perform inter‐laboratory exercises and the need to analyze appropriate quality controls in each sample sequence is highlighted. Other crucial steps in WBE, such as sample collection and sample pre‐treatment, are briefly and carefully discussed. The article further focuses on the potential of high‐resolution mass spectrometry. Different approaches for target and non‐target analysis are discussed, and the interest to perform experiments under laboratory‐controlled conditions, as a complementary tool to investigate related compounds (e.g., minor metabolites and/or transformation products in wastewater) is treated. The article ends up with the trends and future perspectives in this field from the authors’ point of view. © 2016 by The Authors. Mass Spectrometry Reviews published by Wiley Periodicals, Inc. Mass Spec Rev 37:258–280, 2018
format Online
Article
Text
id pubmed-6191649
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61916492018-10-22 Mass spectrometric strategies for the investigation of biomarkers of illicit drug use in wastewater Hernández, Félix Castiglioni, Sara Covaci, Adrian de Voogt, Pim Emke, Erik Kasprzyk‐Hordern, Barbara Ort, Christoph Reid, Malcolm Sancho, Juan V. Thomas, Kevin V. van Nuijs, Alexander L.N. Zuccato, Ettore Bijlsma, Lubertus Mass Spectrom Rev Review Articles The analysis of illicit drugs in urban wastewater is the basis of wastewater‐based epidemiology (WBE), and has received much scientific attention because the concentrations measured can be used as a new non‐intrusive tool to provide evidence‐based and real‐time estimates of community‐wide drug consumption. Moreover, WBE allows monitoring patterns and spatial and temporal trends of drug use. Although information and expertise from other disciplines is required to refine and effectively apply WBE, analytical chemistry is the fundamental driver in this field. The use of advanced analytical techniques, commonly based on combined chromatography—mass spectrometry, is mandatory because the very low analyte concentration and the complexity of samples (raw wastewater) make quantification and identification/confirmation of illicit drug biomarkers (IDBs) troublesome. We review the most‐recent literature available (mostly from the last 5 years) on the determination of IDBs in wastewater with particular emphasis on the different analytical strategies applied. The predominance of liquid chromatography coupled to tandem mass spectrometry to quantify target IDBs and the essence to produce reliable and comparable results is illustrated. Accordingly, the importance to perform inter‐laboratory exercises and the need to analyze appropriate quality controls in each sample sequence is highlighted. Other crucial steps in WBE, such as sample collection and sample pre‐treatment, are briefly and carefully discussed. The article further focuses on the potential of high‐resolution mass spectrometry. Different approaches for target and non‐target analysis are discussed, and the interest to perform experiments under laboratory‐controlled conditions, as a complementary tool to investigate related compounds (e.g., minor metabolites and/or transformation products in wastewater) is treated. The article ends up with the trends and future perspectives in this field from the authors’ point of view. © 2016 by The Authors. Mass Spectrometry Reviews published by Wiley Periodicals, Inc. Mass Spec Rev 37:258–280, 2018 John Wiley and Sons Inc. 2016-10-17 2018 /pmc/articles/PMC6191649/ /pubmed/27750373 http://dx.doi.org/10.1002/mas.21525 Text en © 2016 by The Authors. Mass Spectrometry Reviews published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Review Articles
Hernández, Félix
Castiglioni, Sara
Covaci, Adrian
de Voogt, Pim
Emke, Erik
Kasprzyk‐Hordern, Barbara
Ort, Christoph
Reid, Malcolm
Sancho, Juan V.
Thomas, Kevin V.
van Nuijs, Alexander L.N.
Zuccato, Ettore
Bijlsma, Lubertus
Mass spectrometric strategies for the investigation of biomarkers of illicit drug use in wastewater
title Mass spectrometric strategies for the investigation of biomarkers of illicit drug use in wastewater
title_full Mass spectrometric strategies for the investigation of biomarkers of illicit drug use in wastewater
title_fullStr Mass spectrometric strategies for the investigation of biomarkers of illicit drug use in wastewater
title_full_unstemmed Mass spectrometric strategies for the investigation of biomarkers of illicit drug use in wastewater
title_short Mass spectrometric strategies for the investigation of biomarkers of illicit drug use in wastewater
title_sort mass spectrometric strategies for the investigation of biomarkers of illicit drug use in wastewater
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191649/
https://www.ncbi.nlm.nih.gov/pubmed/27750373
http://dx.doi.org/10.1002/mas.21525
work_keys_str_mv AT hernandezfelix massspectrometricstrategiesfortheinvestigationofbiomarkersofillicitdruguseinwastewater
AT castiglionisara massspectrometricstrategiesfortheinvestigationofbiomarkersofillicitdruguseinwastewater
AT covaciadrian massspectrometricstrategiesfortheinvestigationofbiomarkersofillicitdruguseinwastewater
AT devoogtpim massspectrometricstrategiesfortheinvestigationofbiomarkersofillicitdruguseinwastewater
AT emkeerik massspectrometricstrategiesfortheinvestigationofbiomarkersofillicitdruguseinwastewater
AT kasprzykhordernbarbara massspectrometricstrategiesfortheinvestigationofbiomarkersofillicitdruguseinwastewater
AT ortchristoph massspectrometricstrategiesfortheinvestigationofbiomarkersofillicitdruguseinwastewater
AT reidmalcolm massspectrometricstrategiesfortheinvestigationofbiomarkersofillicitdruguseinwastewater
AT sanchojuanv massspectrometricstrategiesfortheinvestigationofbiomarkersofillicitdruguseinwastewater
AT thomaskevinv massspectrometricstrategiesfortheinvestigationofbiomarkersofillicitdruguseinwastewater
AT vannuijsalexanderln massspectrometricstrategiesfortheinvestigationofbiomarkersofillicitdruguseinwastewater
AT zuccatoettore massspectrometricstrategiesfortheinvestigationofbiomarkersofillicitdruguseinwastewater
AT bijlsmalubertus massspectrometricstrategiesfortheinvestigationofbiomarkersofillicitdruguseinwastewater